2502 — Henan Jinyuan Hydrogenated Chemicals Co Balance Sheet
0.000.00%
- HK$382.26m
- HK$478.73m
- CNY3.10bn
- 38
- 78
- 20
- 41
Annual balance sheet for Henan Jinyuan Hydrogenated Chemicals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 54.4 | 50.1 | 92.5 | 301 | 353 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 130 | 132 | 162 | 111 | 70.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 295 | 317 | 352 | 552 | 591 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 587 | 592 | 671 | 983 | 952 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 972 | 974 | 1,075 | 1,663 | 1,676 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 419 | 380 | 260 | 383 | 457 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 571 | 515 | 493 | 642 | 691 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 402 | 459 | 582 | 1,022 | 985 |
| Total Liabilities & Shareholders' Equity | 972 | 974 | 1,075 | 1,663 | 1,676 |
| Total Common Shares Outstanding |